TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q1 2022 Results - Earnings Call Transcript

TFF Pharmaceuticals, Inc. (NASDAQ:NASDAQ:TFFP) Q1 2022 Earnings Conference Call May 11, 2022, 16:30 ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President, CEO...

Related Keywords

Geneva ,Genè ,Switzerland ,Boston ,Massachusetts ,United States ,Canada ,Texas ,Washington ,University Of Texas ,Kirk Coleman ,Ted Ross ,Ted Ketterer ,Mayank Mamtani ,Dale Christensen ,Bill Williams ,Yuan Zhi ,Richard Deutsch ,Anthony Pogesma ,Corey Davis ,Albert Einstein ,Daniel Carlson ,Jonathan Aschoff ,Leo Serresino ,Company Participants ,Safety Management Committee ,National Securities ,Nasdaq ,Pfizer ,Tk Associates ,Tff Pharmaceuticals Inc ,Pharmaceuticals Inc ,Pharmaceuticals First Quarter Financial ,Clinical Development ,Geneva Foundation ,York Stock Exchange ,Union Therapeutics ,University Of Texas At Austin ,Exchange Commission ,New York Stock Exchange ,Business Development ,Itw Research ,Conference Call May ,First Quarter ,First Quarter Financial ,Business Results Conference ,Glenn Mattes ,Chief Financial Officer ,Chris Cano ,Risk Factors ,Torreya Partners ,Thin Film ,Thin Film Freezing ,United States Army Medical Research Institute ,Infectious Diseases ,Middle East ,Kartik Chandran ,Drew Weissman ,New York Stock ,Washington Capital ,Glass House ,